Contribution: Industrial Research Assistance Program – Contributions to Firms
Sepset Biosciences Inc.
$50,000.00
Identifying sepsis and predicting sepsis severity in the emergency room: Multi-centre, international clinical study to refine novel gene signature
FY 2018-19 · 2018-05-01
Summary
Sepset is developing a blood test to provide doctors with earlier, more reliable, and actionable data to identify sepsis and predict sepsis severity. This project is to statistically validate and refine a gene signature that will be compatible in a clinical platform.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
805251790
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2019-05-31
Agreement Number
905969
Agreement Start Date
2018-05-01
Agreement Title
Identifying sepsis and predicting sepsis severity in the emergency room: Multi-centre, international clinical study to refine novel gene signature
Agreement Title (French)
Déterminer la sepsie et prévoir la gravité de sepsie dans la salle d’urgence : essai clinique multicentrique internationale pour raffiner la signature génétique
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Sepset is developing a blood test to provide doctors with earlier, more reliable, and actionable data to identify sepsis and predict sepsis severity. This project is to statistically validate and refine a gene signature that will be compatible in a clinical platform.
Description (French)
Sepset est en train de développer une analyse de sang pour fournir aux médecins des données plus tôt, plus fiables, et exploitables afin de déterminer la sepsie et prévoir la gravité de la sepsie. Ce projet est de valider statistiquement et de raffiner une signature génétique, qui sera compatible dans une plate-forme de clinique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
5419
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
805251790
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Sepset Biosciences Inc.
Recipient Operating Name
Sepset
Recipient Postal Code
V6T 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q1-905969
